These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38133797)

  • 1. Pediatric diffuse glioma with EP300::BCOR fusion manifesting as low-grade epilepsy-associated neuroepithelial tumor: a case presentation.
    Nakata S; Arai Y; Fukuoka K; Shirakura T; Yamazaki A; Osawa S; Hama N; Shibata T; Miyagishima T; Horiguchi K; Tosaka M; Yokoo H; Yoshimoto Y; Nobusawa S
    Brain Tumor Pathol; 2024 Jan; 41(1):35-39. PubMed ID: 38133797
    [No Abstract]   [Full Text] [Related]  

  • 2. High-grade neuroepithelial tumor with BCOR exon 15 internal tandem duplication-a comprehensive clinical, radiographic, pathologic, and genomic analysis.
    Ferris SP; Velazquez Vega J; Aboian M; Lee JC; Van Ziffle J; Onodera C; Grenert JP; Saunders T; Chen YY; Banerjee A; Kline CN; Gupta N; Raffel C; Samuel D; Ruiz-Diaz I; Magaki S; Wilson D; Neltner J; Al-Hajri Z; Phillips JJ; Pekmezci M; Bollen AW; Tihan T; Schniederjan M; Cha S; Perry A; Solomon DA
    Brain Pathol; 2020 Jan; 30(1):46-62. PubMed ID: 31104347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent EP300-BCOR Fusions in Pediatric Gliomas With Distinct Clinicopathologic Features.
    Torre M; Meredith DM; Dubuc A; Solomon DA; Perry A; Vasudevaraja V; Serrano J; Snuderl M; Ligon KL; Alexandrescu S
    J Neuropathol Exp Neurol; 2019 Apr; 78(4):305-314. PubMed ID: 30816933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The EP300:BCOR fusion extends the genetic alteration spectrum defining the new tumoral entity of "CNS tumors with BCOR internal tandem duplication".
    Tauziède-Espariat A; Pierron G; Siegfried A; Guillemot D; Uro-Coste E; Nicaise Y; Castel D; Catalaa I; Larrieu-Ciron D; Chaynes P; de Barros A; Nicolau J; Gareton A; Lechapt E; Chrétien F; Bourdeaut F; Doz F; Bouchoucha Y; Grill J; Beccaria K; Boddaert N; Saffroy R; Pagès M; Varlet P
    Acta Neuropathol Commun; 2020 Nov; 8(1):178. PubMed ID: 33138864
    [No Abstract]   [Full Text] [Related]  

  • 5. BCOR::CREBBP fusion in malignant neuroepithelial tumor of CNS expands the spectrum of methylation class CNS tumor with BCOR/BCOR(L1)-fusion.
    Ebrahimi A; Waha A; Schittenhelm J; Gohla G; Schuhmann MU; Pietsch T
    Acta Neuropathol Commun; 2024 Apr; 12(1):60. PubMed ID: 38637838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-grade neuroepithelial tumor with EP300::BCOR fusion and negative BCOR immunohistochemical expression: a case report.
    Sugino H; Satomi K; Mori T; Mukai Y; Honda-Kitahara M; Matsushita Y; Ichimura K; Narita Y; Yoshida A
    Brain Tumor Pathol; 2023 Apr; 40(2):133-141. PubMed ID: 36811792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central nervous system high grade neuroepithelial tumor with BCOR immunopositivity: Is there a molecular heterogeneity?
    Rao S; Mitra S; Sugur H; Vazhayil V; Rao BRM; Annayappa SK; Nandeesh BN; Yasha TC; Santosh V
    Brain Tumor Pathol; 2021 Jan; 38(1):41-49. PubMed ID: 32980923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffusely infiltrating glioma with CREBBP-BCORL1 fusion showing overexpression of not only BCORL1 but BCOR: A case report.
    Yamazaki A; Arai Y; Fukuoka K; Nakano Y; Hama N; Nakata S; Makino K; Kuroda JI; Shinojima N; Mukasa A; Mikami Y; Ichimura K; Shibata T; Yokoo H; Nobusawa S
    Brain Tumor Pathol; 2022 Jul; 39(3):171-178. PubMed ID: 35596897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CNS tumor with EP300::BCOR fusion: discussing its prevalence in adult population.
    Tauziède-Espariat A; Uro-Coste E; Sievers P; Nicaise Y; Mariet C; Siegfried A; Pierron G; Guillemot D; Benzakoun J; Pallud J; Roques M; Bonneville F; Larrieu-Ciron D; Chaynes P; Saffroy R; Hamelin J; Hasty L; Métais A; Chrétien F; Kool M; Gojo J; Varlet P;
    Acta Neuropathol Commun; 2023 Feb; 11(1):26. PubMed ID: 36782314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CNS high-grade neuroepithelial tumor with BCOR internal tandem duplication: a comparison with its counterparts in the kidney and soft tissue.
    Yoshida Y; Nobusawa S; Nakata S; Nakada M; Arakawa Y; Mineharu Y; Sugita Y; Yoshioka T; Araki A; Sato Y; Takeshima H; Okada M; Nishi A; Yamazaki T; Kohashi K; Oda Y; Hirato J; Yokoo H
    Brain Pathol; 2018 Sep; 28(5):710-720. PubMed ID: 29226988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular and clinicopathologic characteristics of gliomas with EP300::BCOR fusions.
    Wu Z; Rajan S; Chung HJ; Raffeld M; Panneer Selvam P; Schweizer L; Perry A; Samuel D; Giannini C; Ragunathan A; Frosch MP; Marshall MS; Boué DR; Donev K; Neill SG; Fernandes I; Resnick A; Rood B; Cummings TJ; Buckley AF; Szymanski L; Neto OLA; Zach L; Colman H; Cheshier S; Ziskin J; Tyagi M; Capper D; Abdullaev Z; Cimino PJ; Quezado M; Pratt D; Aldape K
    Acta Neuropathol; 2022 Dec; 144(6):1175-1178. PubMed ID: 36201019
    [No Abstract]   [Full Text] [Related]  

  • 12. CNS tumor with CREBBP::BCORL1 Fusion and pathogenic mutations in BCOR and CREBBP: expanding the spectrum of BCOR-altered tumors.
    Barresi V; Cardoni A; Miele E; Pedace L; Masotto B; Nardini C; Barresi S; Rossi S
    Acta Neuropathol Commun; 2024 Jan; 12(1):8. PubMed ID: 38216991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early Wound Site Seeding in a Patient with Central Nervous System High-Grade Neuroepithelial Tumor with BCOR Alteration.
    Kirkman MA; Pickles JC; Fairchild AR; Avery A; Pietsch T; Jacques TS; Aquilina K
    World Neurosurg; 2018 Aug; 116():279-284. PubMed ID: 29859355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of BCOR Internal Tandem Duplications in Pediatric Cancers by Targeted RNA Sequencing.
    Al-Ibraheemi A; Putra J; Tsai HK; Cano S; Lip V; Pinches RS; Restrepo T; Alexandrescu S; Janeway KA; Duraisamy S; Harris MH; Church AJ
    J Mol Diagn; 2021 Oct; 23(10):1269-1278. PubMed ID: 34325058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case of the month 1-2019: CNS high-grade neuroepithelial tumor with
    Haberler C; Reiniger L; Rajnai H; Kalev O; Gelpi E; Tamesberger M; Pietsch T
    Clin Neuropathol; 2019; 38(1):4-7. PubMed ID: 30526817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A single supratentorial high-grade neuroepithelial tumor with two distinct BCOR mutations, exceptionally long complete remission and survival.
    Bremer J; Kottke R; Johann PD; von Hoff K; Brazzola P; Grotzer MA; Kool M; Rushing E; Gerber NU
    Pediatr Blood Cancer; 2020 Jul; 67(7):e28384. PubMed ID: 32383815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HGNET-BCOR Tumors of the Cerebellum: Clinicopathologic and Molecular Characterization of 3 Cases.
    Appay R; Macagno N; Padovani L; Korshunov A; Kool M; André N; Scavarda D; Pietsch T; Figarella-Branger D
    Am J Surg Pathol; 2017 Sep; 41(9):1254-1260. PubMed ID: 28704208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphous low-grade neuroepithelial tumor of the young (PLNTY): an epileptogenic neoplasm with oligodendroglioma-like components, aberrant CD34 expression, and genetic alterations involving the MAP kinase pathway.
    Huse JT; Snuderl M; Jones DT; Brathwaite CD; Altman N; Lavi E; Saffery R; Sexton-Oates A; Blumcke I; Capper D; Karajannis MA; Benayed R; Chavez L; Thomas C; Serrano J; Borsu L; Ladanyi M; Rosenblum MK
    Acta Neuropathol; 2017 Mar; 133(3):417-429. PubMed ID: 27812792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central nervous system high-grade neuroepithelial tumor with BCOR alteration (CNS HGNET-BCOR)-case-based reviews.
    De Lima L; Sürme MB; Gessi M; Mastronuzzi A; Miele E; Tamburrini G; Massimi L
    Childs Nerv Syst; 2020 Aug; 36(8):1589-1599. PubMed ID: 32542405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the basal cell carcinoma pathway in a patient with CNS HGNET-BCOR diagnosis: consequences for personalized targeted therapy.
    Paret C; Theruvath J; Russo A; Kron B; El Malki K; Lehmann N; Wingerter A; Neu MA; Gerhold-Ay A; Wagner W; Sommer C; Pietsch T; Seidmann L; Faber J
    Oncotarget; 2016 Dec; 7(50):83378-83391. PubMed ID: 27825128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.